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Abstract 
The following presents a primary care optometry encounter with a patient who has recovered from 
COVID-19. This article aims to highlight the potential for optometry to contribute to a better 
understanding of the visual and retinal manifestations of patients diagnosed with COVID-19. 
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Abstract: 
Healthy 31-year-old COVID19 survivor, Mrs CV, presented for routine eye examination in 
Brisbane Australia.  
 
Mild hyper reflective lesions at the level of the ganglion cell and inner plexiform layers in 
both eyes were detected, and slight vascular distension of the inferior vascular arcades 
observed in the LE with optical coherence tomography (OCT), as well as slight central visual 
field defect in the right eye. In isolation both these subclinical observations are important, but 
together they point to further research required specifically in the area of the form and 
function of the papillomacular bundle and the way it responds to neuro invasive viral 
infection. 
 
Still the absence of cotton wool spots and the absence of micro-haemorrhages means that 
there is not sufficient evidence of retinopathy and she remains subclinical with further review 
examinations pending.  
 
This primary care optometry encounter with a patient who has recovered from COVID19 
highlights the current gaps in knowledge, as well as the importance of peer reviewed 





Coronaviridae affect different parts of the body including the nervous system and ocular 
tissues.(1) Further, coronaviridae are often highly contagious.(2) Since SARS-CoV-2 first 
began spreading in Wuhan, has been a particular challenge when diagnosing, containing and 
treating the novel coronavirus COVID19. (3) 
 
Infection control and PPE use has been an important part of clinical competence in order to 
safely examine patients for some time.(4) The use of PPE has become more pertinent recently 
since the COVID19 outbreak (5) but has long been a part of primary eye care; for example 
when treating epidemic keratoconjunctivitis adenovirus.(6) Ocular tropism of viruses means 
that contact with ocular tissues can be a mode of transmission.(7) Virus particles can infect 
the ocular surface and later spread to develop systemic symptoms.(8) This requires that 
goggles, gloves and gown be worn by a health carer, and, strict hygiene procedures and 
infection control measures be put in place for those working with a person with active 
COVID19 infection.(9)  
 
Despite this Australia, with our early contact with COVID19 cases and yet relatively low 
COVID19 case load, has been able to focus on containing outbreaks of community 
transmission, developing safe and effective treatments and vaccine trials, and now; providing 
vigilant health care to the survivors of COVID19. (10)  
 
Primary eye care has ongoing contact with patients,(11) some may be asymptomatic, or pre 
symptomatic and otherwise undiagnosed, and others that have recovered from COVID19.(12) 
A comprehensive eye examination requires close contact which can put both clinician and 
patient at risk.(13) Practicing optometrists should have an adequate understanding of COVID 
safe practice and the potential for clinically significant and subclinical retinal change in 
COVID19 survivors.  
 
Recent Lancet correspondence reported retinal changes in a group of adults with symptomatic 
COVID19 infection. (14) All twelve had fever, asthenia, and dyspnoea and 11 out of twelve 
also presented with anosmia. All twelve showed hyper-reflective lesions at the level of the 
ganglion cell layer and inner plexiform layers that were most prominent in the papillomacular 
bundle in both eyes.(14) Four of these patients showed subtle cotton wool spots and micro 
haemorrhages in the retinal arcades. Visual acuity and pupil reflexes were normal for this 
group and there were no visual field test results published. Marinho etal contend that 
ganglion cell and plexiform layer changes could be associated with CNS manifestations that 
have also been described in animal studies (15) and in COVID19 related neurological 
events(16). Australian eye care professionals are well placed to begin to answer the questions 




Case study involves OCT and VF assessment of a 31 yo female, Mrs CV who reported 
testing positive to COVID19 in March after flying to Brisbane from London 12 weeks ago. 
She did have some anosmia at the time, which also reduced her sense of taste at the time. She 
reported no vision changes, no hearing or balance changes, no skin sensation changes on the 
face or body, no blink disturbances, no speech or swallowing problems and was able to 
exercise rigorously on her treadmill throughout the COVID19 infection. MrsCV generously 
consented to this case study. 
 
She had slightly reduced unaided vision RE 6/6 compared to LE 6/5, with no improvement 
with PH or refraction. No symptoms or signs of intraocular inflammation detected. BV was 
normal. Stereopsis normal. She reported slight colour difference with the RE duller than the 
LE but still passed all Ishihara slides without errors for each eye. Amsler grid was stable and 
given for home monitoring. Pupillary reflexes were normal. [see report]. Wide view retinal 
scan and corneal topography results were normal R&L. 
 
OCT scans and fundus photography were largely normal with no cotton wool spots and 
microhaemorrhages observed. [see results] Mild hyper-reflective lesions at the level of 
ganglion cell and inner plexiform layers in both eyes were found. [see Topcon report] These 
were mild in comparison to the hyper-reflective lesions described by Marinho etal. There was 
some asymmetry noted in the prominence of the inferior vascular arcades with the L side 
thicker than the R side. Both of these signs are so slight as to be in the order of magnitude of 
a possible artefact. Repeat OCT (as per Marinho etal) with another OCT instrument found 
similar subclinical results.[see Canon reports]  
 
Humphries VF test is an important test to help link changes in retinal form with visual 
function. Mrs CV has completed a 24-2 Sita fast R&L and 30-2 Standard test R&L. The first 
24-2 test was unreliable, RE was ONL. Repeat 30-2 standard VF test confirmed only a small 
central upper temporal quadrant relative VF change which significantly may be associated 
with mild dysfunction of the inferior papillomacular GCL bundle. [see VF reports] 
 
Mrs CV is being monitored monthly to determine if these lesions will spontaneously resolve, 
and retinal thickness of the inferior arcades return to normal and central VF test results 























The neurologic manifestations of severe respiratory viral contagions have been understood 
for some time.(19) There has been some published ongoing research into the potential for 
CNS damage from corona virus and similar infection. (18) (20) Importantly SARS Co-V-2 
showed potential as a highly neuroinvasive and neurotropic pathogen and at the very least has 
shown to be during acute stage of the disease in humans to date.(5)  
 
OCT has become an important diagnostic tool with a range of retinal conditions. Some sight 
threatening retinal change is linked to systemic disease, such as diabetes, or even 
demyelinating neurological conditions such as MS. PreCOVID19 there has been a great deal 
of literature discussing the significance of non-sight-threatening OCT changes and early 
detection of changes in populations with Alzheimer’s and cognitive decline.(21) The elderly 
are particularly prone to glaucoma and this has been a confounding factor in the construction 
of a definitive OCT screener for Alzheimer's.(22) 
 
To date published ocular manifestations have focused on oculartropism and viral 
conjunctivitis which are both important with ensuring COVID safe practice.(8)  
But recently published clinical observations have returned the focus to subtle retinal 
changes.(9) Even though non sight threatening, if these novel retinal clinical findings are 
confirmed within various surviving COVID19 populations, there are important implications 
for safety and efficacy of current cohort of COVID19 vaccinations and the general 
epidemiological management of COVID19. Until clearly defined, the precautionary principle 
is important to consider with respect to policy provision. Further, principles of safety and 
effectivity, encompassing the opposing problems of under-diagnosis and over diagnosis, are 
key to informing evolving post COVID19 professional clinical judgment and practice. 
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